Sinco Pharmaceuticals : INSIDE INFORMATION - REPAYMENT OF LOAN

Hong Kong Exchanges and Clearing Limited and The Stock Exchange of Hong Kong Limited take no responsibility for the contents of this announcement, make no representations as to its accuracy or completeness and expressly disclaim any liability whatsoever for any loss howsoever arising from or in reliance upon the whole or any part of the contents of this announcement.

Sinco Pharmaceuticals Holdings Limited

興科蓉醫藥控股有限公司

(Incorporated under the laws of the Cayman Islands with limited liability)

(Stock Code: 6833)

INSIDE INFORMATION - REPAYMENT OF LOAN

This announcement is made by the Company pursuant to Rule 13.09 of the Listing Rules and the Inside Information Provisions (as defined in the Listing Rules) under Part XIVA of the Securities and Futures Ordinance (Chapter 571 of the Laws of Hong Kong).

Reference is made to the Company's announcements dated 23 April 2018, 27 March 2019 and 9 April 2019 in relation to, among other things, the Loan. Unless otherwise stated, terms used in this announcement shall have the same meanings as those defined in the Company's announcement dated 27 March 2019 in relation to the Supplemental Agreement.

The Board announces that, on 3 January 2020, the Company has arranged for the repayment of the Loan in the principal amount of RMB140,000,000, together with relevant interest amounts, under the Loan Agreement (as supplemented by the Supplemental Agreement). In such connection, the 1,049,990,000 Shares, representing approximately 62.06% of the Company's issued share capital, charged to Mr. Gui and placed in a custodian account pursuant to the Loan Agreement will be released, and the guarantee provided by Mr. Huang in connection with the Loan will be accordingly released.

By the order of the Board

Sinco Pharmaceuticals Holdings Limited

Huang Xiangbin

Chairman and Executive Director

Sichuan, the PRC, 3 January 2020

As at the date of this announcement, the executive directors of the Company are Mr. Huang Xiangbin and Ms. Zhang Zhijie; and the independent non-executive directors of the Company are Mr. Lau Ying Kit, Mr. Wang Qing and Mr. Liu Wenfang.